Min.Order / FOB Price:Get Latest Price
1 Kilogram |
FOB Price:USD 260.0000 -500.0000 |
Edoxaban factory price High purity 99%
Why is SINOWAY:
1) Specialized in pharmaceutical and healthcare industrial for 34 years.
2) ISO 9001:2015 & SGS audited supplier .
3) Accept various payment terms : T.T 30-60 days.
4) We have warehouse in USA with quickly shipment .
5) We can do different terms of FOB ,CIF/CIP ,DDP ...
Why choose us
1. best quality in your requirement
2. competitive price in china market
3. mature technical support
4. professional logistic support
5. full experience of large numbers containers loading in chinese sea port
6. fast shipment by reputed shipping line
7. packing with pallet as buyer's special request
8. best service after shipment with email !
9. cargoes together with container after-sales service available
10. full experience in export
11. raw materials from chinese origin
Product Information
Product Name | 99% Edoxaban |
CAS | 1229194-11-9 |
Appearance | white powder |
Molecular formula | C24H30ClN7O4S |
Molecular Weight | 738.27 |
Assay | 99%min, 98.0% --101.0% |
Shelf Life | 24 months when properly stored |
Storage | Keep in a cool, dry, dark location |
What is Edoxaban (tosylate Monohydrate) Edoxaban (tosylate Monohydrate) is an oral anticoagulant drug which acts as a direct factor Xa inhibitor. Edoxaban (tosylate Monohydrate) was developed by Daiichi Sankyo and approved in July 2011 in Japan for prevention of venous thromboembolisms (VTE) following lower-limb orthopedic surgery. Edoxaban (tosylate Monohydrate) was also approved by the FDA in January 2015 for the prevention of stroke and non-central-nervous-system systemic embolism. |
Usage
Function of Edoxaban (tosylate Monohydrate)
1.Edoxaban (tosylate Monohydrate) is used for Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following 5 to 10 days of initial therapy with a parenteral anticoagulant.To reduce the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF).
2. Limitations of use
Edoxaban (tosylate Monohydrate) should not be used in nonvalvular atrial fibrillation (NVAF) patients with a creatinine clearance (CrCl) greater than 95 mL/minute because of an increased risk of ischemic stroke compared to warfarin.
Application of Edoxaban (tosylate Monohydrate)
1.Edoxaban (tosylate Monohydrate) is used for Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following 5 to 10 days of initial therapy with a parenteral anticoagulant.To reduce the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF).
2. Limitations of use
Edoxaban (tosylate Monohydrate) should not be used in nonvalvular atrial fibrillation (NVAF) patients with a creatinine clearance (CrCl) greater than 95 mL/minute because of an increased risk of ischemic stroke compared to warfarin.
CAS NO:33069-62-4
CAS NO:68890-66-4
CAS NO:69388-79-0
CAS NO:1492-18-8
CAS NO:23828-92-4
CAS NO:361442-04-8
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View